Anti retroviral Therapy for HIV Infection in 1998, Part 3
Article Abstract:
The International AIDS Society-USA recommends early antiviral therapy, guided by viral load monitoring, for people infected with HIV. Patients effectively treated with a combination of protease inhibitor and reverse transcriptase inhibitor antiretroviral medications for over 2 years do not develop drug-resistant viral mutations. Early drug treatment substantially reduces hospitalizations and illness among HIV patients. Viral load monitoring can indicate the effectiveness of drug treatment regimens and guide changes in therapy.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
Anti retroviral Therapy for HIV Infection in 1998, Part 4
Article Abstract:
The International AIDS Society-USA recommends early antiviral therapy, guided by viral load monitoring, for people infected with HIV. Patients effectively treated with a combination of protease inhibitor and reverse transcriptase inhibitor antiretroviral medications for over 2 years do not develop drug-resistant viral mutations. Early drug treatment substantially reduces hospitalizations and illness among HIV patients. Viral load monitoring can indicate the effectiveness of drug treatment regimens and guide changes in therapy.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
Anti retroviral Therapy for HIV Infection in 1998, Part 5
Article Abstract:
The International AIDS Society-USA recommends early antiviral therapy, guided by viral load monitoring, for people infected with HIV. Patients effectively treated with a combination of protease inhibitor and reverse transcriptase inhibitor antiretroviral medications for over 2 years do not develop drug-resistant viral mutations. Early drug treatment substantially reduces hospitalizations and illness among HIV patients. Viral load monitoring can indicate the effectiveness of drug treatment regimens and guide changes in therapy.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Seroprevalence of HIV infection in the general population of the Cote d'Ivoire, West Africa. The epidemic of HIV AIDS in Abidjan, Cote d'Ivoire: a review of data collected by Projet RETRO-CI from 1987 to 1993
- Abstracts: Proinflammatory cytoline production and cartilage damage due to rheumatoid synovial T helper-1 activation is inhibited by interleukin-4
- Abstracts: HIV and HAART in 1997. Common Oral Manifestations Seen in Patients with HIV/AIDS
- Abstracts: A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure
- Abstracts: Recovery of the Immune System With Antiretroviral Therapy, Part 2. Recovery of the Immune System With Antiretroviral Therapy, Part 1